National Health Act 1953 Amendment Determination under section 84AH (2011) (No. 3) (No. PB 45 of 2011) (Cth)

Case

PB 45 of 2011

Amendment Determination under section 84AH of the National Health Act 1953 (2011) (No. 3)

National Health Act 1953

___________________________________________________________________________

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AH of the National Health Act 1953.

Dated   16   June 2011

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the Amendment Determination under section 84AH of the National Health Act 1953 (2011) (No.3).

(2)This Instrument may also be cited as PB 45 of 2011.

2              Commencement

    This Instrument commences on 1 July 2011.

3              Amendments to PB 58 of 2007

Schedule 1 amends the legislative instrument titled Determination under section 84AH of the National Health Act 1953 (PB 58 of 2007) (as amended).

.

Schedule 1                   Amendments

  1. Schedule 1, after entry for Clonazepam in the form Oral liquid 2.5 mg per mL, 10 mL:

omit:

Clonazepam Injection 1 mg in 1 mL and 1 mL diluent Injection

and substitute in the columns in the order indicated:

Clonazepam

Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)

Injection

  1. Schedule 1, after entry for Cyclosporin in the form Capsule 10 mg:

omit:

Cyclosporin Solution concentrate for intravenous infusion 50 mg in 1 mL Injection

and substitute in the columns in the order indicated:

Cyclosporin Solution concentrate for I.V. infusion 50 mg in 1 mL Injection
  1. Schedule 1, after entry for Digoxin:

 omit:

Erythromycin Powder for intravenous infusion containing 1 g (as lactobionate) Injection

and substitute in the columns in the order indicated:

Erythromycin

Powder for I.V. infusion 1 g (as lactobionate)

Injection

  1. Schedule 1, after entry for Frusemide

omit:

Glyceryl trinitrate Sublingual spray, 400 micrograms per dose Sublingual

and substitute in the columns in the order indicated:

Glyceryl Trinitrate Sublingual spray (pump pack) 400 micrograms per dose, 200 doses Sublingual

[5]   Schedule 1, after entry for Ketoprofen

insert in the columns in the order indicated:

Lacosamide Oral solution 15 mg per mL, 200 mL Oral

[6]   Schedule 1, after entry for Methadone in the form Injection containing methadone hydrochloride 10 mg in 1 mL

omit:

Metronidazole Suppository 500 mg, Rectal
Metronidazole Oral suspension 200 mg (as benzoate) per 5 mL, 100 mL Oral

and substitute in the columns in the order indicated:

Metronidazole Suppositories 500 mg, 10 Rectal
Metronidazole Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL Oral

[7]   Schedule 1, after entry for Naproxen

 omit:

Nevirapine Oral suspension, 10 mg per mL, 240 mL Oral
Oestradiol Vaginal tablet, 25 micrograms Vaginal

and substitute in the columns in the order indicated:

Nevirapine Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL Oral
Oestradiol Vaginal tablets 25 micrograms, 15 Vaginal

[8]   Schedule 1, after entry for Paracetamol in the form Tablet 665 mg (modified release)

omit:

Paracetamol Suppository 500 mg Rectal
Prochlorperazine Suppository 15 mg, containing prochlorperazine maleate 25 mg Rectal

and substitute in the columns in the order indicated:

Paracetamol Suppositories 500 mg, 24 Rectal
Prochlorperazine Suppositories containing prochlorperazine equivalent to 25 mg prochlorperazine maleate, 5 Rectal

[9]   Schedule 1, after entry for Terbinafine

omit:

Tipranavir Oral solution, 100 mg per mL, 95 mL Oral

and substitute in the columns in the order indicated:

Tipranavir Oral liquid 100 mg per mL, 95 mL Oral

[10]   Schedule 1, after entry for Tramadol

 omit:

Valganciclovir Powder for oral solution, 50 mg per mL, 100 mL Oral
Valproic Acid Crushable tablet containing sodium valproate 100 mg Oral

and substitute in the columns in the order indicated:

Valganciclovir Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL Oral
Valproic Acid Tablet, crushable, containing sodium valproate 100 mg Oral

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.

See

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0